Andy Batts
Long only, value, growth, momentum

Anika Therapeutics: Orthobiologics And Aesthetic Dermatology To Drive Growth

Anika Therapeutics (NASDAQ:ANIK) manufactures and distributes a diverse portfolio of hyaluronic acid-based products covering a broad range of therapeutic applications. Anika's stock has seen a decent rally of ~25% since October. I expect the sock to appreciate further from the current level around $31 driven by the robust growth of the company's orthobiologics and aesthetic dermatology products.

Business Overview

Anika develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid ("HA"), also known as hyaluronan, a naturally occurring biocompatible polymer found in the body. Anika produces a variety of HA products, such as liquids, gels, powders and sponge-like membranes, and packages these products for convenient delivery.

Anika's orthobiologics products...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details